With the competition struggling, Pfizer's COVID vaccine sales could hit $24B this year: analyst

Retrieved on: 2021-04-19 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

With the competition struggling, Pfizer's COVID vaccine sales could hit $24B this year: analyst. View article details on hiswai:

Excerpt

It's about Pfizer and BioNTech's more extensive manufacturing network, Gal wrote to clients Monday. The adjusted prediction comes after safety ...

Article found on: www.fiercepharma.com